Table 3.
Kinetic Properties of SHV-1 and Asn276Asp for Clavulanate, Cephalothin BATSIs, Methylidene Penem, and Meropenem
| SHV-1 | Asn276Asp | |
|---|---|---|
| Clavulanate | ||
| Ki(μM) | 1.37 ± 0.23 | 7.44 ± 0.84 |
| KI(μM) | 0.72 ± 0.11 | 1.12 ± 0.11 |
| kinact (s−1) | 0.015 ± 0.002 | 0.015 ± 0.002 |
| kinact/KI (μM−1 s−1) | 0.021 ± 0.004 | 0.013 ± 0.002 |
| kcat/kinact (tn) | 40 ± 10 | 50 ± 10 |
| kcat (s−1) | 0.60 ± 0.17 | 0.75 ± 0.18 |
| Achiral Cephalothin BATSI | ||
| Ki(μM) | 42 ± 4 | 36 ± 4 |
| Chiral Cephalothin BATSI | ||
| Ki(μM) | 0.68 ± 0.07 | 3.8 ± 0.4 |
| Methylidene Penem | ||
| Ki(μM) | 0.057 ± 0.006 | 0.102 ± 0.001 |
| Ki(μM) | 0.026 ± 0.004 | 0.039 ± 0.002 |
| kinact (s−1) | 0.17 ± 0.01 | 0.24 ± 0.02 |
| kinact/KI (μM−1 s−1) | 6.5 ± 1.0 | 6.2 ± 0.6 |
| kcat/kinact (tn) | 2 ± 1 | 2 ± 1 |
| kcat (s−1) | 0.34 ± 0.17 | 0.48 ± 0.24 |
| Meropenem | ||
| Ki(μM) | 31 ± 3 | 1411 ± 14 |